SEC Form 4 · accession 0001104659-15-050232
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Philip Gottlieb
Officer — VP Marketing & Bus Development
Period of report
Jul 7, 2015
Accepted (ET)
Jul 8, 2015 · 8:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2015 | A | 1,965 | $8.84 | A | 1,965 | D | |
| Common Stock | Jul 7, 2015 | S | 1,965 | $16.86 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2These shares, acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c), were sold under Rule 144 and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2015.